Boardroom Alpha
Meeting calendar
DORM · Annual meeting · Friday, May 15, 2026

Dorman Products Inc

8 nominees · 4 ballot items.

Elect eight directors; approve, on an advisory basis, executive compensation (say-on-pay); ratify KPMG LLP as independent auditor for 2026; and approve the Dorman Products, Inc. 2026 Omnibus Incentive Plan (1,543,000-share reserve).

Market cap
$4.2B
1Y TSR
+9.4%
Board grade
B
Record date
Mar 25, 2026
Filing
DEF 14A
Meeting concluded · May 15, 2026

Follow how the vote landed and what changed on Dorman Products Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Election of eight directors

    ManagementBoard: FOR

    Election of eight nominees nominated by the Board to serve until the next annual meeting.

  2. 2

    Advisory approval of the compensation of Dorman’s named executive officers

    ManagementBoard: FOR

    Non-binding advisory vote (say-on-pay) to approve the compensation of the company’s named executive officers as disclosed in the proxy statement.

    More detail

    This management-sponsored, non-binding say-on-pay proposal asks shareholders to approve the overall compensation of Dorman’s named executive officers as disclosed in the proxy. Management presents its executive compensation program as designed to align pay with the Company’s strategic annual plan and long-term growth and to incentivize profitable performance and shareholder value creation. The program emphasizes a majority of pay at risk through annual cash incentives tied to corporate and segment financial metrics (adjusted pre-tax income, net sales, and free cash flow measures) and long-term equity awards split between time-based restricted stock units and performance-based restricted stock units (RTSR and ROIC metrics). The Compensation Committee uses benchmarking and an independent consultant to set targets and believes the mix of short- and long-term incentives, stock ownership guidelines, anti-hedging/pledging policies, caps on awards, and clawback policies mitigate excessive risk-taking. The Board recommends “FOR” because it views the structure as competitively aligned with peers, supportive of retention and motivation of executives, and closely tied to measurable performance outcomes. The advisory nature of the vote means the Board and Compensation Committee will consider shareholder feedback but are not legally bound by the result; management notes previous strong shareholder support for annual say-on-pay votes. If significant shareholder opposition emerges, the Compensation Committee states it will evaluate and consider adjustments to compensation practices. Overall, the proposal is governance-focused rather than transaction-related and is intended to provide shareholders an annual opportunity to express views on executive pay.

  3. 3

    Ratification of KPMG LLP as Dorman’s independent registered public accounting firm for 2026

    ManagementBoard: FOR

    Ratify the appointment of KPMG LLP as Dorman’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

  4. 4

    Approval of the Dorman Products, Inc. 2026 Omnibus Incentive Plan

    ManagementBoard: FOR

    Approve the 2026 Omnibus Incentive Plan, authorizing up to 1,543,000 new shares (plus remaining 2018 Plan shares) for equity and cash awards over a ten-year term to replace the 2018 Equity Plan.

    More detail

    This management proposal asks shareholders to approve a comprehensive equity and cash incentive plan replacing the existing 2018 Equity Plan and authorizing a new reserve of 1,543,000 shares (plus any remaining 2018 Plan available shares) for grants over a ten-year term. Management’s rationale is to maintain a competitive, flexible compensation tool to align employee and director incentives with long-term shareholder value through a mix of award types (options, SARs, restricted stock/units, and cash awards). The Compensation Committee consulted an independent compensation consultant and analyzed burn rate, dilution, and peer practices to determine the size of the share reserve and believes the requested share pool represents approximately 5.2% of diluted shares as of March 9, 2026, with an estimated share-pool duration of about eight years under historical grant practices. The Plan includes governance features intended to protect shareholders, including limits on annual awards to non-employee directors (aggregate grant-date value plus cash fees capped at $750,000), no repricing of options or SARs without shareholder approval, clawback/recoupment policies, and adjustments provisions for corporate changes and changes-in-control. If approved, the Plan will permit continued grantmaking for retention, recruitment, and performance alignment and will allow the Company to transition unallocated shares from the 2018 Plan into the new plan. The Board recommends approval on the basis that an active long-term equity program is a central element of total compensation, supports retention of key talent, and aligns executives’ rewards with multi-year financial metrics and relative total shareholder return benchmarks. The proposal is significant for governance and compensation because it authorizes material potential dilution and long-term incentive mechanics; shareholders should weigh the trade-off between dilution and management’s ability to attract and align talent. The Committee retained discretion in award design and has set caps and performance-based features to mitigate dilution and encourage measurable outcomes tied to shareholder value creation.

Director elections

Nominees on the ballot8

Not independent
Tenure on this board
7.5 yrs
Also a director at
Twin Disc Inc (TWIN)
Independent
Tenure on this board
8.7 yrs
Also a director at
Ugi Corp (UGI)Leonabio Inc (LONA)
Independent
Tenure on this board
4.7 yrs
Also a director at
Vontier Corp (VNT)
Ownership

Top institutional holders10

Latest 13F quarter
1BlackRock, Inc.9.7%2,886,745$301M
2VANGUARD PORTFOLIO MANAGEMENT LLC5.0%1,504,640$157M
3VANGUARD CAPITAL MANAGEMENT LLC4.1%1,237,454$129M
4STATE STREET CORP3.7%1,099,272$115M
5DIMENSIONAL FUND ADVISORS LP3.4%1,020,325$106M
6BlackRock, Inc.2.7%796,626$83M
7JENNISON ASSOCIATES LLC2.1%617,696$64M
8ROYCE ASSOCIATES LP2.1%616,656$64M
9GEODE CAPITAL MANAGEMENT, LLC2.1%616,121$64M
10Invesco Ltd.1.7%521,091$54M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Dorman Products Inc 2026 annual meeting?
Dorman Products Inc (DORM) holds its 2026 annual shareholder meeting on Friday, May 15, 2026.
What is the record date for the Dorman Products Inc 2026 meeting?
The record date for the Dorman Products Inc 2026 meeting is Wednesday, March 25, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Dorman Products Inc's 2026 meeting?
The board is presenting 8 director nominees at the Dorman Products Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Dorman Products Inc 2026 meeting?
Shareholders will vote on 4 proposals at the Dorman Products Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer